[1] NHCPRC. Information[EB/OL]. [2023-02-16]. http://www.nhc.gov,cn/wjw/xinx/xinxi.shtml. [2] MAN CX, ZHOU WJ, YANG SP, et al.Study on narcotics and psychotropic substances control (part X): comparative study on domestic and foreign control system of narcotics and psychotropic substances[J]. Ching Pharmacy(中国药房), 2017, 28(1):23-26. [3] FAN YY, QI YY, MU XJ, et al.Suggestions on improvement of administrative regulations on narcotic drugs and psychotropic drugs in China[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(1): 28-31. [4] XIE DR, YANG HP, ZHU LR, et al.Problems and solutions of the enforcement of usage regulation on narcotic drugs and psychotropic substances in medical institutions[J]. China Pharmacy(中国药房), 2013, 24(25): 2397-2400. [5] LU XJ, SHI XF, ZHANG XF, et al.Analysis of narcotics drugs use among outpatients at a hospital: based on individual data[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2021, 41(10): 1049-1053. [6] National Health Commission of the People's Republic of China. Notice on strengthening the control of narcotic drugs and category I psychotropic drugs in medical institutions[EB/OL]. (2020-09-15)[2023-02-16].http://www.nhc.gov.cn/yzygj/s7659/202009/ee4a21c2756f440e98f78d2533d7539a.shtml. [7] LIU R, GU BA QN, ZHU Q.Application of focal-PDCA in reducing error rate of pharmacy allocation[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2020, 40(24) :2595-2599, 2610. [8] SHI HL, CHEN D, HUANG LX.Department of anesthesiology, psychotropic drugs of category I used in the refined management of drug circulation of FOCUS-PDCA in our hospital[J]. Chinese Journal of Rational Drug Use(中国合理用药探索), 2017, 14(1): 31-33,41. [9] SHI XF, SUN ZY, WANG XY, et al.Application of quality control circle in the management of drug repercussion in outpatient pharmacy of our hospital[J]. Ching Pharmacy(中国药房), 2018, 29(1): 25-28. [10] JIAO Y, SONG YX, ZHANG J, et al.Discussion on using quality control circle to improve the qualified rate of anesthesia prescription in our hospital[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2020, 55(11): 951-954. [11] ZENG HL, ZHU YC.Application of quality control circle in improving prescription qualification rate of narcotic drugs and category I psychotropic drugs in our hospital[J]. Strait Pharmaceutical Journal(海峡药学), 2019, 31(9): 284-285. [12] WANG MK, SUN XH.Outpatient pharmacy intervention to promote rational use of narcotic and psychotropic drugs prescription[J].Shenzhen Journal of Integrated Traditional Chinese and Western Medical(深圳中西医结合杂志), 2020, 30(24): 103-104. [13] LI GS, WU MX.Application of PDCA cycle method in standard management and use of anesthetic drugs in our hospital[J]. Strait Pharmaceutical Journal(海峡药学), 2020, 32(2): 171-173. [14] VAN DBEMHJ, VAN KSMJ, JANSSEN DJA, et al.Treatment of pain in cancer: towards personalised medicine[J]. Cancers (Basel), 2018, 10(12): 502. [15] ZHANG XF, SHI XF, LU XJ, et al.Fine setting and implementation effect evaluation of the use rules for narcotic drugs and psychotropic drugs based on outpatient prescription pre-review system[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2022, 42(9): 935-939. [16] ZUO J, LI X, LIAO LN, et al.Analysis of implementation of pre-prescription review system in our hospital[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2019, 39(22): 2338-2341. [17] ZHANG XF, SHI XF, LU XJ, et al.Practice of outpatient prescription review based on clinical rational drug use intelligent management system[J]. Herald of Medicine(医药导报), 2021, 40(6): 837-841. [18] XING XY, ZHANG H, CHAO H, et al.Closed-loop management of narcotic and psychotropic drugs based on HIS system[J]. Perioperative Safety and Quality Assurance(麻醉安全与质控) , 2021, 5(2): 97-99. [19] LIU D, LI GH, ZHAO RS, et al.Expert consensus on information management of narcotic drugs and class I psychotropic substances in medical institutions[J]. Herald of Medicine(医药导报), 2022, 41(1): 1-7. |